Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Prenatal Diagnosis|May 31, 2021
Challenges in providing residual risks in carrier testingRobert Luke Nussbaum, Robert Nathan Slotnick, Neil J RischJournal of Psychiatric Practice|January 27, 2026
Enhancing Training and Education on Treatment Readiness in Personality Disorders: A Case-based DiscussionConnor Hawkins, David Kealy, Robert Nathan, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 16, 2003
Seasonal versus perennial allergic rhinitis: drug and medical resource use patternsWilliam H Crown, Abayomi Olufade, Mark W Smith, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 12, 2009
Update on the safety of long-acting beta-agonists in combination with inhaled corticosteroids for the treatment of asthmaHarold S Nelson, Warner Carr, Robert Nathan, et al.Archives of Pediatrics & Adolescent Medicine|November 4, 2009
Case-control study of a gastroschisis cluster in NevadaLeslie Elliott, Dana Loomis, Lisa Lottritz, et al.The Journal of Allergy and Clinical Immunology|December 11, 2012
Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitisEli O Meltzer, Michael Schatz, Robert Nathan, et al.Current Medical Research and Opinion|July 25, 2017
Healthcare costs for allergic rhinitis patients on allergy immunotherapy: a retrospective observational studyFelicia Allen-Ramey, Jianbin Mao, Cori Blauer-Peterson, et al.Obstetrics and Gynecology|November 4, 2021
Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care VisitsShivani Nazareth, Laura Hayward, Emilie Simmons, et al.Allergy and Asthma Proceedings|June 25, 2009
Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America surveyEli O Meltzer, Robert Nathan, Jennifer Derebery, et al.Respiratory Research|June 14, 2020
A phase IIb, randomised, parallel-group study: the efficacy, safety and tolerability of once-daily umeclidinium in patients with asthma receiving inhaled corticosteroidsEdward Kerwin, Steven Pascoe, Zelie Bailes, et al.Pageof 2